|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 178.81 USD | +3.99% |
|
+6.73% | -20.76% |
| 10:48pm | Lilly's obesity pill draws 1,390 US prescriptions in launch week | RE |
| 08:53pm | Lilly's Foundayo hits 1,390 prescriptions in debut week | RE |
| Capitalization | 28.86B 24.51B 22.63B 21.34B 39.58B 2,686B 40.27B 265B 104B 1,292B 108B 106B 4,594B | P/E ratio 2026 * |
21.2x | P/E ratio 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise value | 41.86B 35.55B 32.82B 30.94B 57.4B 3,895B 58.4B 385B 151B 1,874B 157B 154B 6,663B | EV / Sales 2026 * |
2.43x | EV / Sales 2027 * | 2.25x |
| Free-Float |
67.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Iqvia Holdings Inc.
| 1 day | +4.03% | ||
| 1 week | +6.57% | ||
| Current month | +4.57% | ||
| 1 month | +5.88% | ||
| 3 months | -23.69% | ||
| 6 months | -12.82% | ||
| Current year | -20.89% |
| 1 week | 166.26 |  | 180.72 |
| 1 month | 162.36 | | 180.72 |
| Current year | 156.66 | | 247.04 |
| 1 year | 134.64 | | 247.04 |
| 3 years | 134.64 | | 261.73 |
| 5 years | 134.64 | | 285.61 |
| 10 years | 61.21 | | 285.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 65 | 03/10/2016 |
Michael Fedock
DFI | Director of Finance/CFO | 50 | 28/02/2026 |
Jeffrey Spaeder
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Leonard
BRD | Director/Board Member | 68 | 05/02/2015 |
Ari Bousbib
CHM | Chairman | 65 | 03/10/2016 |
Todd Sisitsky
BRD | Director/Board Member | 54 | 01/01/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.55% | 1.54% | 26 M€ | |
| -.--% | 1.2% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.99% | +6.57% | +23.92% | -11.99% | 28.86B | |
| +2.29% | +5.40% | +0.67% | -8.03% | 47.35B | |
| +1.13% | +4.34% | +39.89% | +22.02% | 35.57B | |
| -1.58% | +52.46% | +299.95% | +498.37% | 31.16B | |
| +3.47% | +3.72% | +36.62% | +29.82% | 29.62B | |
| +1.08% | +2.02% | +47.90% | +194.97% | 15.01B | |
| +0.26% | +4.73% | +74.45% | +164.36% | 14.73B | |
| -3.39% | +2.21% | +3,744.11% | +3,944.12% | 15.12B | |
| +1.79% | +9.82% | +42.14% | +14.57% | 14.34B | |
| +0.09% | +0.30% | +165.48% | +99.56% | 12.43B | |
| Average | +0.89% | +8.89% | +447.51% | +494.78% | 24.42B | |
| Weighted average by Cap. | +1.28% | +10.42% | +301.60% | +339.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.24B 14.64B 13.52B 12.74B 23.64B 1,604B 24.05B 158B 62.1B 772B 64.68B 63.33B 2,744B | 18.25B 15.5B 14.31B 13.49B 25.02B 1,698B 25.46B 168B 65.72B 817B 68.45B 67.02B 2,904B |
| Net income | 1.46B 1.24B 1.14B 1.08B 2B 135B 2.03B 13.37B 5.24B 65.15B 5.46B 5.35B 232B | 1.7B 1.44B 1.33B 1.26B 2.33B 158B 2.37B 15.61B 6.12B 76.04B 6.37B 6.24B 270B |
| Net Debt | 13B 11.04B 10.19B 9.61B 17.82B 1,209B 18.13B 119B 46.81B 582B 48.75B 47.74B 2,069B | 12.2B 10.36B 9.57B 9.02B 16.74B 1,136B 17.03B 112B 43.96B 546B 45.78B 44.83B 1,943B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/04/26 | 179.10 $ | +4.16% | 216,472 |
| 16/04/26 | 171.95 $ | -3.45% | 1,536,819 |
| 15/04/26 | 178.10 $ | +1.61% | 1,288,262 |
| 14/04/26 | 175.28 $ | +1.91% | 1,238,111 |
| 13/04/26 | 171.99 $ | +2.78% | 1,401,717 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IQV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition